Part 3/9:
Under the guidance of Dr. James Walsh, the clinical trial's principal investigator, Jack joins a handful of volunteers. During the orientation, the feeling is electric yet ominous as volunteers are briefed on the drug’s mechanics, potential side effects, and the daily examinations they would undergo. The lightness of the opening moments starts to dim, as genuine concerns about the trial are voiced, foreshadowing the chaos that is to unfold.